BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25314065)

  • 21. S100P Expression via DNA Hypomethylation Promotes Cell Growth in the Sessile Serrated Adenoma/Polyp-Cancer Sequence.
    Takahashi S; Okamoto K; Tanahashi T; Fujimoto S; Nakagawa T; Bando M; Ma B; Kawaguchi T; Fujino Y; Mitsui Y; Kitamura S; Miyamoto H; Sato Y; Muguruma N; Bando Y; Sato T; Fujimori T; Takayama T
    Digestion; 2021; 102(5):789-802. PubMed ID: 33395688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia.
    Hua X; Newcomb PA; Chubak J; Malen RC; Ziebell R; Kamineni A; Zhu LC; Upton MP; Wurscher MA; Thomas SS; Newman H; Hardikar S; Burnett-Hartman AN
    Cancer Causes Control; 2020 Jul; 31(7):631-640. PubMed ID: 32358694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Biomarkers of Sessile Serrated Adenoma/Polyps.
    Kanth P; Boylan KE; Bronner MP; Boucher KM; Hazel MW; Yao R; Pop S; Bernard PS; Delker DA
    Clin Transl Gastroenterol; 2019 Dec; 10(12):e00104. PubMed ID: 31789933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.
    Sugai T; Eizuka M; Fujita Y; Kawasaki K; Yamamoto E; Ishida K; Yamano H; Suzuki H; Matsumoto T
    Dig Dis Sci; 2018 Oct; 63(10):2626-2638. PubMed ID: 29974407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy.
    Spring KJ; Zhao ZZ; Karamatic R; Walsh MD; Whitehall VL; Pike T; Simms LA; Young J; James M; Montgomery GW; Appleyard M; Hewett D; Togashi K; Jass JR; Leggett BA
    Gastroenterology; 2006 Nov; 131(5):1400-7. PubMed ID: 17101316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sessile serrated adenoma/polyps with a depressed surface: a rare form of sessile serrated adenoma/polyp.
    Lee EJ; Kim MJ; Chun SM; Jang SJ; Kim DS; Lee DH; Youk EG
    Diagn Pathol; 2015 Jun; 10():75. PubMed ID: 26088907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The proto CpG island methylator phenotype of sessile serrated adenomas/polyps.
    Parker HR; Orjuela S; Martinho Oliveira A; Cereatti F; Sauter M; Heinrich H; Tanzi G; Weber A; Komminoth P; Vavricka S; Albanese L; Buffoli F; Robinson MD; Marra G
    Epigenetics; 2018; 13(10-11):1088-1105. PubMed ID: 30398409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of histologically distinct conventional adenomas that arise predominately in patients with sessile serrated adenomas.
    Pai RK; Mackinnon AC; Joseph L; Noffsinger A; Hart J
    Am J Surg Pathol; 2010 Mar; 34(3):355-63. PubMed ID: 20118768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics.
    Rosty C; Buchanan DD; Walsh MD; Pearson SA; Pavluk E; Walters RJ; Clendenning M; Spring KJ; Jenkins MA; Win AK; Hopper JL; Sweet K; Frankel WL; Aronson M; Gallinger S; Goldblatt J; Woodall S; Arnold J; Walker NI; Jass JR; Parry S; Young JP
    Am J Surg Pathol; 2012 Jun; 36(6):876-82. PubMed ID: 22510757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer.
    Greenspan EJ; Cyr JL; Pleau DC; Levine J; Rajan TV; Rosenberg DW; Heinen CD
    Carcinogenesis; 2007 Apr; 28(4):769-76. PubMed ID: 17088260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans.
    Rosenberg DW; Yang S; Pleau DC; Greenspan EJ; Stevens RG; Rajan TV; Heinen CD; Levine J; Zhou Y; O'Brien MJ
    Cancer Res; 2007 Apr; 67(8):3551-4. PubMed ID: 17440063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of regenerating gene Iα appears to reflect aberration of crypt cell compartmentalization in sessile serrated adenoma/polyps of the colon.
    Okamoto K; Fujimori T; Yamaguchi T; Ichikawa K; Tomita S; Sugai T; Imura J; Ohkura Y; Yao T; Fujii S; Kusaka T; Sekikawa A; Fukui H; Chiba T; Kato H; Mitomi H
    Diagn Pathol; 2013 Nov; 8():187. PubMed ID: 24225137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
    Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
    Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reappraisal of the genetic heterogeneity of sessile serrated adenoma/polyp.
    Cho H; Hashimoto T; Yoshida H; Taniguchi H; Ogawa R; Mori T; Hiraoka N; Saito Y; Sekine S
    Histopathology; 2018 Oct; 73(4):672-680. PubMed ID: 29920740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps.
    Sandmeier D; Benhattar J; Martin P; Bouzourene H
    Histopathology; 2009 Aug; 55(2):206-13. PubMed ID: 19694828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pedunculated serrated polyp with histologic features of sessile serrated adenoma: a clinicopathologic and molecular study.
    Kim MJ; Lee EJ; Chun SM; Jang SJ; Kim CH; Seo JP; Kim DS; Lee DH; Lee SH; Youk EG
    Am J Surg Pathol; 2013 Jul; 37(7):1039-43. PubMed ID: 23648458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
    van Roon EH; van Puijenbroek M; Middeldorp A; van Eijk R; de Meijer EJ; Erasmus D; Wouters KA; van Engeland M; Oosting J; Hes FJ; Tops CM; van Wezel T; Boer JM; Morreau H
    BMC Cancer; 2010 May; 10():180. PubMed ID: 20444249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
    Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF
    Fennell LJ; Jamieson S; McKeone D; Corish T; Rohdmann M; Furner T; Bettington M; Liu C; Kawamata F; Bond C; Van De Pols J; Leggett B; Whitehall V
    BMC Cancer; 2018 Jan; 18(1):35. PubMed ID: 29304767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.